Novelix Pharmaceuticals standalone net profit rises 307.69% in the September 2025 quarter
Sales rise 818.18% to Rs 36.36 crore
Net profit of Novelix Pharmaceuticals rose 307.69% to Rs 0.53 crore in the quarter ended September 2025 as against Rs 0.13 crore during the previous quarter ended September 2024. Sales rose 818.18% to Rs 36.36 crore in the quarter ended September 2025 as against Rs 3.96 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var.Sales36.363.96 818 OPM %1.935.30 -PBDT0.730.13 462 PBT0.720.13 454 NP0.530.13 308Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 14 2025 | 7:47 AM IST